# Quebec SEAO #20182080

Polytechnique Montréal seeks an Eppendorf BioFlo320 bioreactor system

**Posted:** November 06, 2026
**Respond By:** November 21, 2026
**Identifier:** 20182080
**NAICS:** 423490

Polytechnique Montréal is seeking supplier input on a proposed sole-source purchase of an Eppendorf BioFlo320 bioreactor system for cell-culture research and production.
- **Government buyer:** École Polytechnique (Polytechnique Montréal).
- **OEM and named supplier:** **Eppendorf** is the BioFlo320 manufacturer; **Eppendorf Canada Ltd.** is the proposed supplier.
- **Requested system:** One BioFlo320 bioreactor system; quantity and part number are not specified. Supply and installation are requested.
- **Purpose and capabilities:** Supports mammalian cell culture, including CHO-cell vaccine production and protein production such as monoclonal antibodies. Requires oxygen, pH, and temperature control; fed-batch or continuous operation; and working volumes from under 1 litre to 40 litres.
- **Vessels and controls:** Must support autoclavable glass and single-use plastic vessels; single-use operation can be enabled with an Eppendorf conversion kit. Additional requirements include multi-point dissolved-oxygen control, scale-up calculations, customizable control loops, configurable alarms, remote notifications, and remote process monitoring and control through DASware Control software.
- **Notable procurement rationale:** Polytechnique identifies compatibility with systems already used by the institution and its NRC partners, alongside the system’s technical capabilities, as the basis for its sole-source intent. Suppliers are invited to provide evidence that they can meet the requirements and delivery timeframe.

### Description

Polytechnique Montréal intends to award a sole-source contract to Eppendorf Canada Ltd. to supply and install a BioFlo320 bioreactor system for mammalian cell culture. The system will support a collaborative CHO-cell vaccine production platform and other projects producing proteins such as monoclonal antibodies. Required capabilities include control of oxygen, pH, and temperature, fed-batch or continuous operation, and working volumes from under 1 litre to 40 litres. Suppliers may respond by the stated deadline to demonstrate that they can supply the requested goods; responses will help determine whether a competitive solicitation should be launched.

[View original listing](https://seao.gouv.qc.ca/avis-resultat-recherche/consulter?ItemId=39219ddc-b031-4599-b63c-074871308abb)